ACS chemical neuroscience molecule spotlight on Viibryd (vilazodone)

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

On January 21, 2011, the U.S. Food and Drug Administration approved Viibryd, a new selective serotonin reuptake inhibitor (SSRI), to treat major depressive disorder in adults developed by Clinical Data, Inc.

Original languageEnglish (US)
Number of pages1
JournalACS Chemical Neuroscience
Volume2
Issue number10
DOIs
StatePublished - Oct 19 2011

Fingerprint

Major Depressive Disorder
Serotonin Uptake Inhibitors
United States Food and Drug Administration
Neurosciences
Molecules
Vilazodone Hydrochloride

Keywords

  • Depression
  • SSRI
  • antidepressant
  • major depressive disorder

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Cite this

ACS chemical neuroscience molecule spotlight on Viibryd (vilazodone). / Hopkins, Corey R.

In: ACS Chemical Neuroscience, Vol. 2, No. 10, 19.10.2011.

Research output: Contribution to journalArticle

@article{0491bf389b584aaab3fb4377e0c8c879,
title = "ACS chemical neuroscience molecule spotlight on Viibryd (vilazodone)",
abstract = "On January 21, 2011, the U.S. Food and Drug Administration approved Viibryd, a new selective serotonin reuptake inhibitor (SSRI), to treat major depressive disorder in adults developed by Clinical Data, Inc.",
keywords = "Depression, SSRI, antidepressant, major depressive disorder",
author = "Hopkins, {Corey R.}",
year = "2011",
month = "10",
day = "19",
doi = "10.1021/cn200084v",
language = "English (US)",
volume = "2",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "10",

}

TY - JOUR

T1 - ACS chemical neuroscience molecule spotlight on Viibryd (vilazodone)

AU - Hopkins, Corey R.

PY - 2011/10/19

Y1 - 2011/10/19

N2 - On January 21, 2011, the U.S. Food and Drug Administration approved Viibryd, a new selective serotonin reuptake inhibitor (SSRI), to treat major depressive disorder in adults developed by Clinical Data, Inc.

AB - On January 21, 2011, the U.S. Food and Drug Administration approved Viibryd, a new selective serotonin reuptake inhibitor (SSRI), to treat major depressive disorder in adults developed by Clinical Data, Inc.

KW - Depression

KW - SSRI

KW - antidepressant

KW - major depressive disorder

UR - http://www.scopus.com/inward/record.url?scp=80054956583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054956583&partnerID=8YFLogxK

U2 - 10.1021/cn200084v

DO - 10.1021/cn200084v

M3 - Article

C2 - 22860155

AN - SCOPUS:80054956583

VL - 2

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 10

ER -